Autosomal dominant polycystic kidney disease: The changing face of clinical management

The Lancet

Volumn 385, Issue 9981, 2015, Pages 1993-2002

  Ong, Albert C M ^a,b   Devuyst, Olivier ^c,d   Knebelmann, Bertrand ^e   Walz, Gerd ^f  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATININE; CYCLIC AMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVEROLIMUS; G PROTEIN COUPLED RECEPTOR; LISINOPRIL; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; POLYCYSTIN 1; POLYCYSTIN 2; PRAVASTATIN; RAPAMYCIN; TOLVAPTAN; VASOPRESSIN; MTOR PROTEIN, HUMAN; POLYCYSTIC KIDNEY DISEASE 1 PROTEIN; POLYCYSTIN; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE; TARGET OF RAPAMYCIN KINASE;

ALLELE; APOPTOSIS; ARTICLE; AUTOPSY; CARBOXY TERMINAL SEQUENCE; CELL DIVISION; CELL MIGRATION; CELL PROLIFERATION; CENTROSOMAL FIDELITY; CENTROSOME; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; ECONOMIC ASPECT; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; EUKARYOTIC FLAGELLUM; FAMILY HISTORY; GENE MUTATION; GENETIC SCREENING; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HUMAN; HYPERTENSION; KIDNEY POLYCYSTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PEER GROUP; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SELF CARE; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; STANDARD; ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FORECASTING; GENETICS; MALE; METABOLISM; MIDDLE AGED; MUTATION; PHYSIOLOGY; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CYCLIC AMP; FEMALE; FORECASTING; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TRPP CATION CHANNELS; YOUNG ADULT;

EID: 84929589777     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60907-2     Document Type: Review

References (91)

1. VE Torres, ML Watson Polycystic kidney disease: antiquity to the 20th century Nephrol Dial Transplant 13 1998 2690 2696
2. GB Fogazzi The description of polycystic kidney by Domenico Gusmano Galeazzi Nephrol Dial Transplant 13 1998 1039 1040
3. OZ Dalgaard Bilateral polycystic disease of the kidneys; a follow-up of two hundred and 80-four patients and their families Acta Med Scand 158 suppl 328 1957 1 255
4. KD Gardner Jr Composition of fluid in twelve cysts of a polycystic kidney N Engl J Med 281 1969 985 988
5. ST Reeders, MH Breuning, KE Davies et al. A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16 Nature 317 1985 542 544
6. R Mangoo-Karim, ME Uchic, M Grant et al. Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP FASEB J 3 1989 2629 2632
7. DJ Peters, L Spruit, JJ Saris et al. Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease Nat Genet 5 1993 359 362
8. TEPKD Consortium the The European Polycystic Kidney Disease Consortium The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16 Cell 77 1994 881 894
9. T Mochizuki, G Wu, T Hayashi et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein Science 272 1996 1339 1342
10. CJ Ward, MC Hogan, S Rossetti et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein Nat Genet 30 2002 259 269
11. JJ Grantham, VE Torres, AB Chapman the CRISP Investigators Volume progression in polycystic kidney disease N Engl J Med 354 2006 2122 2130
12. AL Serra, D Poster, AD Kistler et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease N Engl J Med 363 2010 820 829
13. G Walz, K Budde, M Mannaa et al. Everolimus in patients with autosomal dominant polycystic kidney disease N Engl J Med 363 2010 830 840
14. VE Torres, AB Chapman, O Devuyst the TEMPO 3:4 Trial Investigators Tolvaptan in patients with autosomal dominant polycystic kidney disease N Engl J Med 367 2012 2407 2418
15. A Caroli, N Perico, A Perna the ALADIN study group Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial Lancet 382 2013 1485 1495
16. RW Schrier, KZ Abebe, RD Perrone the HALT-PKD Trial Investigators Blood pressure in early autosomal dominant polycystic kidney disease N Engl J Med 371 2014 2255 2266
17. VE Torres, KZ Abebe, AB Chapman the HALT-PKD Trial Investigators Angiotensin blockade in late autosomal dominant polycystic kidney disease N Engl J Med 371 2014 2267 2276
18. JJ Grantham Clinical practice. Autosomal dominant polycystic kidney disease N Engl J Med 359 2008 1477 1485
19. VE Torres, PC Harris, Y Pirson Autosomal dominant polycystic kidney disease Lancet 369 2007 1287 1301
20. TJ Gevers, JP Drenth Diagnosis and management of polycystic liver disease Nat Rev Gastroenterol Hepatol 10 2013 101 108
21. Z Mao, G Xie, AC Ong Metabolic abnormalities in autosomal dominant polycystic kidney disease Nephrol Dial Transplant 30 2015 197 203
22. CG Iglesias, VE Torres, KP Offord, KE Holley, CM Beard, LT Kurland Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980 Am J Kidney Dis 2 1983 630 639
23. KW Chan Adult polycystic kidney disease in Hong Kong Chinese: an autopsy study Pathology 25 1993 229 232
24. KL Lentine, H Xiao, G Machnicki, A Gheorghian, MA Schnitzler Renal function and healthcare costs in patients with polycystic kidney disease Clin J Am Soc Nephrol 5 2010 1471 1479
25. EM Spithoven, A Kramer, E Meijer et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry Nephrol Dial Transplant 29 suppl 4 2014 iv15 iv25
26. BM Paul, MB Consugar, M Ryan Lee et al. Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families Kidney Int 85 2014 383 392
27. RJ Simms, DL Travis, M Durkie, G Wilson, A Dalton, AC Ong Genetic testing in the assessment of living related kidney donors at risk of autosomal dominant polycystic kidney disease Transplantation 2014 10.1097/TP.0000000000000466 published online Oct 21.
28. K Zerres, S Rudnik-Schöneborn, F Deget Childhood onset autosomal dominant polycystic kidney disease in sibs: clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft für Pädiatrische Nephrologie) J Med Genet 30 1993 583 588
29. Y Pei, J Obaji, A Dupuis et al. Unified criteria for ultrasonographic diagnosis of ADPKD J Am Soc Nephrol 20 2009 205 212
30. Y Pei, YH Hwang, J Conklin et al. Imaging-based diagnosis of autosomal dominant polycystic kidney disease J Am Soc Nephrol 26 2015 746 753
31. S Rossetti, K Hopp, RA Sikkink et al. Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing J Am Soc Nephrol 23 2012 915 933
32. E Cornec-Le Gall, MP Audrézet, JM Chen et al. Type of PKD1 mutation influences renal outcome in ADPKD J Am Soc Nephrol 24 2013 1006 1013
33. S Rossetti, MB Consugar, AB Chapman the CRISP Consortium Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease J Am Soc Nephrol 18 2007 2143 2160
34. S Rossetti, VJ Kubly, MB Consugar et al. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease Kidney Int 75 2009 848 855
35. C Bergmann, J von Bothmer, N Ortiz Brüchle et al. Mutations in multiple PKD genes may explain early and severe polycystic kidney disease J Am Soc Nephrol 22 2011 2047 2056
36. RJ Simms, AC Ong How simple are 'simple renal cysts'? Nephrol Dial Transplant 29 suppl 4 2014 iv106 iv112
37. AB Chapman, O Devuyst, KU Eckardt for Conference Participants Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Kidney Int 2015 10.1038/ki.2015.59 published online March 18.
38. O Boyer, MF Gagnadoux, G Guest et al. Prognosis of autosomal dominant polycystic kidney disease diagnosed in utero or at birth Pediatr Nephrol 22 2007 380 388
39. AA Shamshirsaz, M Reza Bekheirnia, M Kamgar et al. Autosomal-dominant polycystic kidney disease in infancy and childhood: progression and outcome Kidney Int 68 2005 2218 2224
40. TA Ho, N Godefroid, D Gruzon et al. Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation Kidney Int 82 2012 1121 1129
41. MA Cadnapaphornchai, K McFann, JD Strain, A Masoumi, RW Schrier Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension Kidney Int 74 2008 1192 1196
42. MA Cadnapaphornchai, DM George, K McFann et al. Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease Clin J Am Soc Nephrol 9 2014 889 896
43. RW Schrier, G Brosnahan, MA Cadnapaphornchai et al. Predictors of autosomal dominant polycystic kidney disease progression J Am Soc Nephrol 25 2014 2399 2418
44. LF Menezes, F Zhou, AD Patterson et al. Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4α as a disease modifier PLoS Genet 8 2012 e1003053
45. N Hateboer, MA v Dijk, N Bogdanova et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group Lancet 353 1999 103 107
46. AD Paterson, R Magistroni, N He et al. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease J Am Soc Nephrol 16 2005 755 762
47. A Persu, M Duyme, Y Pirson et al. Comparison between siblings and twins supports a role for modifier genes in ADPKD Kidney Int 66 2004 2132 2136
48. PC Harris, KT Bae, S Rossetti et al. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease J Am Soc Nephrol 17 2006 3013 3019
49. AB Chapman, JE Bost, VE Torres et al. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease Clin J Am Soc Nephrol 7 2012 479 486
50. MV Irazabal, LJ Rangel, EJ Bergstralh the CRISP Investigators Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials J Am Soc Nephrol 26 2015 160 172
51. E Cornec-Le Gall, Y Le Meur Polycystic kidney disease: kidney volume - a crystal ball for ADPKD prognosis? Nat Rev Nephrol 10 2014 485 486
52. BF King, VE Torres, ME Brummer the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease Kidney Int 64 2003 2214 2221
53. A Caroli, L Antiga, S Conti et al. Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients Am J Pathol 179 2011 619 627
54. AC Ong, PC Harris Molecular pathogenesis of ADPKD: the polycystin complex gets complex Kidney Int 67 2005 1234 1247
55. HC Chapin, MJ Caplan The cell biology of polycystic kidney disease J Cell Biol 191 2010 701 710
56. MY Chang, AC Ong New treatments for autosomal dominant polycystic kidney disease Br J Clin Pharmacol 76 2013 524 535
57. PC Harris, VE Torres Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease J Clin Invest 124 2014 2315 2324
58. F Qian, A Boletta, AK Bhunia et al. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations Proc Natl Acad Sci USA 99 2002 16981 16986
59. Y Cai, SV Fedeles, K Dong et al. Altered trafficking and stability of polycystins underlie polycystic kidney disease J Clin Invest 124 2014 5129 5144
60. D Merrick, H Chapin, JE Baggs et al. The γ-secretase cleavage product of polycystin-1 regulates TCF and CHOP-mediated transcriptional activation through a p300-dependent mechanism Dev Cell 22 2012 197 210
61. SM Nauli, FJ Alenghat, Y Luo et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells Nat Genet 33 2003 129 137
62. PG DeCaen, M Delling, TN Vien, DE Clapham Direct recording and molecular identification of the calcium channel of primary cilia Nature 504 2013 315 318
63. M Delling, PG DeCaen, JF Doerner, S Febvay, DE Clapham Primary cilia are specialized calcium signalling organelles Nature 504 2013 311 314
64. SC Goetz, KV Anderson The primary cilium: a signalling centre during vertebrate development Nat Rev Genet 11 2010 331 344
65. S Lienkamp, A Ganner, G Walz Inversin, Wnt signaling and primary cilia Differentiation 83 2012 S49 S55
66. H Goto, A Inoko, M Inagaki Cell cycle progression by the repression of primary cilia formation in proliferating cells Cell Mol Life Sci 70 2013 3893 3905
67. MY Chang, E Parker, S Ibrahim et al. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models Nephrol Dial Transplant 21 2006 2078 2084
68. JJ Grantham Pathogenesis of renal cyst expansion: opportunities for therapy Am J Kidney Dis 23 1994 210 218
69. E Kim, G Walz Sensitive cilia set up the kidney Nat Med 13 2007 1409 1411
70. M Chaki, R Airik, AK Ghosh et al. Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling Cell 150 2012 533 548
71. GG Slaats, AK Ghosh, LL Falke et al. Nephronophthisis-associated CEP164 regulates cell cycle progression, apoptosis and epithelial-to-mesenchymal transition PLoS Genet 10 2014 e1004594
72. CC Dibble, BD Manning Signal integration by mTORC1 coordinates nutrient input with biosynthetic output Nat Cell Biol 15 2013 555 564
73. WE Braun, JD Schold, BR Stephany, RA Spirko, BR Herts Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study Clin J Am Soc Nephrol 9 2014 881 888
74. KF Erickson, GM Chertow, JD Goldhaber-Fiebert Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease Ann Intern Med 159 2013 382 389
75. VE Torres, PC Harris Strategies targeting cAMP signaling in the treatment of polycystic kidney disease J Am Soc Nephrol 25 2014 18 32
76. C Héliès-Toussaint, L Aarab, JM Gasc, JM Verbavatz, D Chabardès Cellular localization of type 5 and type 6 ACs in collecting duct and regulation of cAMP synthesis Am J Physiol Renal Physiol 279 2000 F185 F194
77. S Rees, W Kittikulsuth, K Roos, KA Strait, A Van Hoek, DE Kohan Adenylyl cyclase 6 deficiency ameliorates polycystic kidney disease J Am Soc Nephrol 25 2014 232 237
78. CR Sussman, CJ Ward, AC Leightner et al. Phosphodiesterase 1A modulates cystogenesis in zebrafish J Am Soc Nephrol 25 2014 2222 2230
79. PD Wilson Apico-basal polarity in polycystic kidney disease epithelia Biochim Biophys Acta 1812 2011 1239 1248
80. AJ Streets, O Wessely, DJ Peters, AC Ong Hyperphosphorylation of polycystin-2 at a critical residue in disease reveals an essential role for polycystin-1-regulated dephosphorylation Hum Mol Genet 22 2013 1924 1939
81. T Ecder, RW Schrier Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease Nat Rev Nephrol 5 2009 221 228
82. H Happé, DJ Peters Translational research in ADPKD: lessons from animal models Nat Rev Nephrol 10 2014 587 601
83. O Devuyst, X Wang, A Serra Vasopressin-2 receptor antagonists in autosomal dominant polycystic kidney disease: from man to mouse and back Nephrol Dial Transplant 26 2011 2423 2425
84. AS Crystal, AT Shaw, LV Sequist et al. Patient-derived models of acquired resistance can identify effective drug combinations for cancer Science 346 2014 1480 1486
85. MJ Niederst, JA Engelman Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer Sci Signal 6 2013 re6
86. JB Wetmore, JP Calvet, AS Yu et al. Polycystic kidney disease and cancer after renal transplantation J Am Soc Nephrol 25 2014 2335 2341
87. V Corradi, F Gastaldon, GM Virzi, C Caprara, F Martino, C Ronco Clinical and laboratory markers of autosomal dominant polycystic kidney disease (adpkd) progression: an overview Minerva Med 105 2015 53 64
88. SJ Rosansky, RJ Glassock Is a decline in estimated GFR an appropriate surrogate end point for renoprotection drug trials? Kidney Int 85 2014 723 727
89. O Devuyst, NV Knoers, G Remuzzi, F Schaefer the Board of the Working Group for Inherited Kidney Diseases of the European Renal Association and European Dialysis and Transplant Association Rare inherited kidney diseases: challenges, opportunities, and perspectives Lancet 383 2014 1844 1859
90. K Petzold, RT Gansevoort, AC Ong et al. Building a network of ADPKD reference centres across Europe: the EuroCYST initiative Nephrol Dial Transplant 29 suppl 4 2014 iv26 iv32
91. O Devuyst, C Antignac, RJ Bindels et al. The ERA-EDTA Working Group on inherited kidney disorders Nephrol Dial Transplant 27 2012 67 69